Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Biomed Res Int, 2015
Animal studies show low acute toxicity, but human safety data remain limited,,
While some individuals may receive IV therapy as often as weekly, its essential to consult with your healthcare provider to determine the most appropriate treatment plan for you
If CNS penetration has not been quantified through CSF sampling or blood-brain barrier permeability assays, treat the peptide as potentially CNS-active and apply full neuropeptide interaction protocols staggered dosing, conservative peptide dose (5070% of standalone effective dose), and behavioral monitoring for serotonergic excess
The presence of multiple amide and amine functionalities supports protonation under positive ion mode conditions
Marty Ross, MD is a passionate Lyme disease educator and clinical expert
